Jorge F Quevedo
Overview
Explore the profile of Jorge F Quevedo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
229
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekulic A, Migden M, Basset-Seguin N, Garbe C, Gesierich A, Lao C, et al.
BMC Cancer
. 2019 Apr;
19(1):366.
PMID: 30999949
Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete. The complete figure legend is.
2.
Sekulic A, Migden M, Basset-Seguin N, Garbe C, Gesierich A, Lao C, et al.
BMC Cancer
. 2017 May;
17(1):332.
PMID: 28511673
Background: In the primary analysis of the ERIVANCE BCC trial, vismodegib, the first US Food and Drug Administration-approved Hedgehog pathway inhibitor, showed objective response rates (ORRs) by independent review facility...
3.
Kohli M, Ho Y, Hillman D, Van Etten J, Henzler C, Yang R, et al.
Clin Cancer Res
. 2017 May;
23(16):4704-4715.
PMID: 28473535
Androgen receptor (AR) variant AR-V7 is a ligand-independent transcription factor that promotes prostate cancer resistance to AR-targeted therapies. Accordingly, efforts are under way to develop strategies for monitoring and inhibiting...
4.
Zhang B, Riska S, Mahoney D, Costello B, Kohli R, Quevedo J, et al.
BJU Int
. 2016 Jul;
119(3):489-495.
PMID: 27410686
Objectives: To evaluate the prognostic significance of germline variation in candidate genes in patients with castration-resistant prostate cancer (CRPC). Methods: Germline DNA was extracted from peripheral blood mononuclear cells of...